Skip to content
10-Q

Quarterly Report

DRUGS MADE IN AMERICA ACQUISITION CORP. DMAA DMAAR DMAAU

0001213900-25-046061

← back to feed
Filed
May 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 20, 2025 33.52M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $347.37K
Current Liabilities Q1 2025 · Dec 31, 2024 $795.67K
Total Liabilities Q1 2025 · Mar 31, 2025 $7.25M
Total Liabilities Q1 2025 · Dec 31, 2024 $795.67K
Current Assets Q1 2025 · Mar 31, 2025 $71.02K
Current Assets Q1 2025 · Dec 31, 2024 $4.99K
Total Assets Q1 2025 · Mar 31, 2025 $232.81M
Total Assets Q1 2025 · Dec 31, 2024 $550.82K